Adrenal Insufficiency: Clinical Trials

219 trials for Adrenal Insufficiency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

110 completed, 39 unknown, 30 recruiting, 13 terminated. 46 Not applicable, 30 Phase 2, 29 Phase 4, 23 Phase 3, 17 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable46Completed 23, Unknown 9, Recruiting 5, Not yet recruiting 4, Active not recruiting 2, Terminated 2, Withdrawn 1
Phase 230Completed 18, Terminated 4, Unknown 4, Withdrawn 3, Recruiting 1
Phase 429Completed 14, Unknown 5, Recruiting 3, Withdrawn 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1
Phase 323Completed 19, Terminated 2, Unknown 2
Phase 117Completed 11, Terminated 2, Withdrawn 2, Recruiting 1, Unknown 1
Early Phase 12Completed 1, Unknown 1

Follow Adrenal Insufficiency: new trials by email Literature Review of Adrenal Insufficiency trials Research Report on Adrenal Insufficiency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
IT and IV Lentiviral Gene Therapy for X-ALD
Intrathecal and intravenous LV gene therapy - X-linked Adrenoleukodystrophy
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute302027-06-012026-09-01
Hydrocortisone Versus Methylprednisolone for the Treatment of Glucocorticoid-Induced Adrenal Insufficiency
Patients will receive 3 mg of methylprednisolone once daily. The dose is administered in the morning (1 ½ tablets of 2 mg Medrol after breakfast)., Patients will receive 15 mg of hydrocortisone daily. The dose is split into 10 mg in the morning after breakfast and 5 mg after 6-7 hours. - Adrenal Insufficiency
Phase 4Not yet recruitingUniversity Medical Centre Ljubljana662026-09-012026-07-14
Evaluation of Circadian Hormonal Balance: LC-MS/MS Measurement of Salivary and Serum Steroids in Patients With Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia, Adrenal Insufficiency
Not yet recruitingAssistance Publique - Hôpitaux de Paris502026-09-012026-07-21
Prevalence of Adrenal Insufficiency and Associated Factors in Rheumatoid Arthritis Patients Using Low-dose Corticosteroids.
ACTH stimulation test, Cortisol - Reumatoid Arthritis, Corticosteroids Adverse Reaction
RecruitingBursa Yuksek Ihtisas Training and Research Hospital1202026-07-312026-10-08
Telehealth Music Therapy for Adults With Endocrine Disorder and Depression
Telehealth Resource Oriented Music Therapy - Type 1 Diabetes, Hashimoto Disease
Not applicableRecruitingAppalachian State University102026-07-162026-07-30
Combination Osilodrostat and Cabergoline in Cushing's Disease
osilodrostat, osilodrostat and cabergoline - Cushing Disease Due to Increased ACTH Secretion
Phase 4Enrolling by invitationUniversity of Basrah502026-05-112026-05-22
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Oral Corticosteroid Tapering Schedule, Ravulizumab, Prednisone/Prednisolone - Generalized Myasthenia Gravis, gMG
Phase 4RecruitingAlexion Pharmaceuticals, Inc.752026-03-042026-04-09
Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.
Ramadan fasting - Primary Adrenal Insufficiency, Ramadan Fasting
Not applicableNot yet recruitingHopital La Rabta352026-01-222026-01-26
Comparison of Glucocorticoid Tapering Schedules in Rheumatoid Arthritis
Prednisolone - Rheumatoid Arthritis (RA)
Phase 4Not yet recruitingSeoul National University Hospital2062025-12-012025-11-25
Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
Healthy Adult, Cushing Syndrome
RecruitingShanghai 6th People's Hospital2202025-09-012025-09-11
Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders
Participants will use the biossensor for 48 h - Cushing Syndrome, Primary Aldosteronism
Not applicableNot yet recruitingUniversity of Sao Paulo General Hospital2462025-06-012025-05-20
SPL Insufficiency Syndrome (SPLIS)/NPHS14: a SPLIS Observational Study and Patient Registry (International)
no intervention - Sphingolipidoses, Enzyme Deficiency
RecruitingUniversity of California, San Francisco1202025-04-222025-10-24
Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
no intervention - Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS)
RecruitingUniversity of California, San Francisco282025-04-222026-08-04
Epidural Spinal Cord Stimulation for Lower-limb Impairment in Adrenomyeloneuropathy
Spinal cord stimulation - Adrenomyeloneuropathy Without Cerebral Involvement
Not applicableRecruitingThird Military Medical University102025-02-102025-01-28
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
semaglutide, Placebo - Healthy Volunteer Study, HPA
Not applicableCompletedUniversity Hospital, Basel, Switzerland222025-01-162026-02-11
Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
complete ACTH stimulation test the day after surgery and complete ACTH stimulation test 1 or 4 week for patients with Adrenal Insufficiency - Primary Aldosteronism, Autonomous Cortisol Secretion
RecruitingQifu Li5212025-01-022026-05-01
Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
OD dual-release Hydrocortisone, TID Hydrocortisone - Diabetes Mellitus, Adrenal Insufficiency
Not applicableWithdrawnVastra Gotaland Region2025-01-012026-07-07
Growing up With the Young Endocrine Support System (YESS!)
YESS! game, Snake '97, Transition-toolkit - Congenital Adrenal Hyperplasia, Hypogonadotropic Hypogonadism
Not applicableNot yet recruitingdr. Laura C. G. de Graaff-Herder1602024-12-012023-09-07
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics
3D printed chewable formulation of hydrocortisone, Oral suspension of hydrocortisone - Adrenal Insufficiency
Phase 4UnknownHospital Universitari Vall d'Hebron Research Institute352024-09-012024-05-30
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
Adrenal Insufficiency, Leukemia, Lymphoblastic, Acute, Pediatric
RecruitingUniversity Children's Hospital Basel402024-08-132026-05-08

Showing 20 of 219. Sign in to see all of them.

Narrower conditions

Adrenoleukodystrophy (62)  ·  Addison Disease (35)  ·  Leukodystrophy, Metachromatic (18)  ·  Leukodystrophy, Globoid Cell (14)  ·  Adrenal Hyperplasia, Congenital (13)  ·  Cushing Syndrome (10)  ·  Peroxisomal Disorders (10)  ·  Metabolism, Inborn Errors (9)  ·  Mucopolysaccharidosis I (9)  ·  Rare Diseases (8)  ·  Sphingolipidoses (8)  ·  Diabetes Mellitus, Type 1 (6)  ·  Gaucher Disease (6)  ·  Hyperaldosteronism (6)

Broader conditions

Adrenal Gland Diseases (219)  ·  Endocrine System Diseases (214)  ·  Nutritional and Metabolic Diseases (99)  ·  Metabolic Diseases (89)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (82)  ·  Nervous System Diseases (82)  ·  Brain Diseases (79)  ·  Genetic Diseases, Inborn (77)  ·  Central Nervous System Diseases (76)  ·  Metabolism, Inborn Errors (69)  ·  Neurologic Manifestations (66)  ·  Intellectual Disability (65)  ·  Neurobehavioral Manifestations (65)  ·  Brain Diseases, Metabolic (63)

Interventions

Hydrocortisone (34)  ·  Cosyntropin (7)  ·  Prednisolone (5)  ·  hydrocortisone hemisuccinate (5)  ·  Alemtuzumab (4)  ·  Blood Specimen Collection (3)  ·  Dehydroepiandrosterone (3)  ·  Dexamethasone (3)  ·  Etomidate (3)  ·  Hematologic Tests (3)  ·  Lorenzo's oil (3)  ·  Melphalan (3)  ·  Prednisone (3)  ·  Stem Cell Transplantation (3)  ·  trierucate (3)

Sponsors

Neurocrine UK Limited (10)  ·  Wuerzburg University Hospital (8)  ·  Haukeland University Hospital (7)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (6)  ·  Masonic Cancer Center, University of Minnesota (6)  ·  Genetix Biotherapeutics Inc. (5)  ·  Assistance Publique - Hôpitaux de Paris (4)  ·  Copenhagen University Hospital, Rigshospitalet (4)  ·  University of Wuerzburg (4)  ·  Hopital La Rabta (3)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (3)  ·  Imperial College London (3)  ·  Pujol, Aurora, M.D. (3)  ·  Shire (3)  ·  University of Roma La Sapienza (3)

Countries

United States (67)  ·  Germany (27)  ·  United Kingdom (25)  ·  France (20)  ·  Italy (15)  ·  Netherlands (15)  ·  China (10)  ·  Norway (8)  ·  Spain (8)  ·  Denmark (7)  ·  Sweden (7)  ·  Canada (6)  ·  Switzerland (6)  ·  Argentina (4)  ·  Australia (4)

Top investigators

Paul Orchard, MD (5)  ·  Bruno Allolio, MD (4)  ·  Stefanie Hahner, MD, Prof. (4)  ·  Joanne Kurtzberg, MD (3)  ·  Karim Meeran, MBBS BSc MD (3)  ·  Ulla Feldt-Rasmussen, Professor (3)  ·  A Koch (2)  ·  Adeline Vanderver, MD (2)  ·  Andrea M Isidori, MD, PhD (2)  ·  Deborah P Merke, M.D. (2)  ·  Gerald V Raymond, M.D. (2)  ·  Girish Sharma (2)  ·  Jens S Christiansen, Professor (2)  ·  John Henderson, MD (2)

Results publications

PMID 39383458, PMID 21586746, PMID 39383459, PMID 10321661, PMID 10697064, PMID 10923728, PMID 11231629, PMID 11399225, PMID 12186604, PMID 1478121, PMID 17684047, PMID 18184957, PMID 18509277, PMID 18784570, PMID 19383806, PMID 19833552, PMID 19892975, PMID 20103758, PMID 21593113, PMID 22073145, PMID 22112807, PMID 2268888, PMID 22855336, PMID 22904181, PMID 22911730, PMID 22990093, PMID 23385627, PMID 23672956, PMID 23761380, PMID 23845948, PMID 23966770, PMID 24170102, PMID 24884782, PMID 24944332, PMID 25066331, PMID 25419882, PMID 25494662, PMID 25619170, PMID 25620457, PMID 25705800, PMID 26067718, PMID 26075496, PMID 26646751, PMID 26914224, PMID 27153945, PMID 27490921, PMID 27680873, PMID 27801983, PMID 28472487, PMID 28521880

NIH funding

2009 (3), 2018 (2), 2014 (1), 2015 (1), 2016 (1), K23NS087151 (1), R01HD113778 (1), U01NS106845 (1), U54NS115052 (1)